Shunhui Wei

Singapore, 308433, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Development and in vitro characterization of humanized antibodies for blocking human TRPM4 channel.

Development and in vitro characterization of humanized antibodies for blocking human TRPM4 channel.

Journal: Scientific reports

Published: December 11, 2024

In vivo evaluation of monoclonal antibody M4M using a humanised rat model of stroke demonstrates attenuation of reperfusion injury via blocking human TRPM4 channel.

In vivo evaluation of monoclonal antibody M4M using a humanised rat model of stroke demonstrates attenuation of reperfusion injury via blocking human TRPM4 channel.

Journal: Journal of drug targeting

Published: February 12, 2024

Enhanced isradipine sensitivity in vascular smooth muscle cells due to hypoxia-induced Cav1.2 splicing and RbFox1/Fox2 downregulation.

Enhanced isradipine sensitivity in vascular smooth muscle cells due to hypoxia-induced Cav1.2 splicing and RbFox1/Fox2 downregulation.

Journal: The FEBS journal

Published: January 29, 2024

Effects of clitorienolactones from Clitoria ternatea root on calcium channel mediating hippocampal long-term potentiation in rats induced chronic cerebral hypoperfusion.

Effects of clitorienolactones from Clitoria ternatea root on calcium channel mediating hippocampal long-term potentiation in rats induced chronic cerebral hypoperfusion.

Journal: Ageing research reviews

Published: December 14, 2023

TRPM4 blocking antibody reduces neuronal excitotoxicity by specifically inhibiting glutamate-induced calcium influx under chronic hypoxia.

TRPM4 blocking antibody reduces neuronal excitotoxicity by specifically inhibiting glutamate-induced calcium influx under chronic hypoxia.

Journal: Neurobiology of disease

Published: June 13, 2023

TRPM4 Blocking Antibody Protects Cerebral Vasculature in Delayed Stroke Reperfusion.

TRPM4 Blocking Antibody Protects Cerebral Vasculature in Delayed Stroke Reperfusion.

Journal: Biomedicines

Published: April 15, 2023

SLC26A11 Inhibition Reduces Oncotic Neuronal Death and Attenuates Stroke Reperfusion Injury.

SLC26A11 Inhibition Reduces Oncotic Neuronal Death and Attenuates Stroke Reperfusion Injury.

Journal: Molecular neurobiology

Published: March 13, 2023

Binding epitope for recognition of human TRPM4 channel by monoclonal antibody M4M.

Binding epitope for recognition of human TRPM4 channel by monoclonal antibody M4M.

Journal: Scientific reports

Published: June 01, 2022

Development and characterization of a monoclonal antibody blocking human TRPM4 channel.

Development and characterization of a monoclonal antibody blocking human TRPM4 channel.

Journal: Scientific reports

Published: September 25, 2020

Comparison of Anti-oncotic Effect of TRPM4 Blocking Antibody in Neuron, Astrocyte and Vascular Endothelial Cell Under Hypoxia.

Comparison of Anti-oncotic Effect of TRPM4 Blocking Antibody in Neuron, Astrocyte and Vascular Endothelial Cell Under Hypoxia.

Journal: Frontiers in cell and developmental biology

Published: May 15, 2020

TRPM4-specific blocking antibody attenuates reperfusion injury in a rat model of stroke.

TRPM4-specific blocking antibody attenuates reperfusion injury in a rat model of stroke.

Journal: Pflugers Archiv : European journal of physiology

Published: July 16, 2019

Directed Differentiation of Human Embryonic Stem Cells to Neural Crest Stem Cells, Functional Peripheral Neurons, and Corneal Keratocytes.

Directed Differentiation of Human Embryonic Stem Cells to Neural Crest Stem Cells, Functional Peripheral Neurons, and Corneal Keratocytes.

Journal: Biotechnology journal

Published: February 13, 2017

Showing 1-12 of 19

Last Updated: 09/26/2026